Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACCES: Saxagliptin in Impaired Glucose Tolerance
NCT01521312Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Sep 2012
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of saxagliptin in impaired glucose tolerance (IGT), sponsored by Assistance publique - Hôpitaux de Paris. Started Sep 2012; status: completed.
02
Drugs
saxagliptin
03
Conditions
impaired glucose tolerance (IGT)
Beyond the preview
Go deeper on NCT01521312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01521312.